FDA Drug recall D-1424-2014
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc.,…
- FDA Drug
- Class II
- terminated
- Published 2014-07-16
On 2014-07-16 the FDA classified a Class II recall of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc.,… by Hospira, citing presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1424-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-05-16 |
| Published | 2014-07-16 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20
Reason
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
Identifiers
| ndc | 0409-2267-20 |
|---|---|
| ndc | 0409-2267-54 |
| ndc | 0409-0125-01 |
| ndc | 0409-0125-25 |
| code_info | Lot 36225DD, exp 12/01/2015 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1424-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.